Merck to get European patent for CRISPR technology – pharmabiz.com
|
Merck to get European patent for CRISPR technology
pharmabiz.com Merck, a leading science and technology company, announced the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck's patent application covering the company's CRISPR technology used in a genomic integration method for … |
